|
Market Closed -
Hong Kong S.E.
01:38:26 14/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 21.32 HKD | +1.43% |
|
+3.50% | -30.05% |
| 24/09 | Medtide Acquires China Land, Property for Peptide CDMO Project | MT |
| 24/09 | Medtide Inc. Announces Resignation of Li Lingmei as Executive Director, Effective September 24, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 38Cr | - | - | |||
| 7.04TCr | |||||
| 5.03TCr | |||||
| 4.75TCr | |||||
| 4.29TCr | |||||
| 4.04TCr | - | - | - | - | - |
- Stock Market
- Stocks
- 3880 Stock
- Charts Medtide Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
